Barbara Thompson

Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

Psychedelics reopen the social reward learning critical period

The Type IV phosphodiesterase inhibitor rolipram interferes with drug‐induced conditioned place preference but not immediate early gene induction in mice

An investigation of the age at menopause